IDDI provides biostatistical and eClinical services to pharmaceutical and biotech companies since 1991.
Bioctogen Boston Corporation is a Biotech CRO offering Immuno-Oncology drug validation services that rely on independently-developed humanized immune-checkpoint mouse models (e.g. B-hPD-1 mice) and immune-deficient, human immune system-reconstituted mice (B-NDG model). Biocytogen also offers antibody humanized mouse models, CDX models, PDX models, in vivo services, PK/PD services, ect. All models are generated by our custom gene targeting platform, featuring CRISPR-based EGE® technology, which increases large fragment knockin efficiency by 10-20-fold. Learn more at www.biocytogen.com.
Applied BioMath provides mechanistic modeling services to help large and small biotechnology and pharmaceutical companies de-risk therapeutic programs. A team of mathematicians, biologists, clinical pharmacologists and pharmaceutical industry experts, they leverage biology, mathematics, proprietary technologies, HPC, and industry experience to perform massive scale simulations which enable groups to determine best-in-class properties of a clinical candidate, reduce attrition rates, and identify key differentiators from competitors.
Committed to healthcare since 2004, LARVOL has been delivering custom intelligence solutions that provide healthcare and life sciences experts accurate, rapid, expertly-curated information to enable strategic decision-making. Specifically in the oncology space, we collate and simplify data from over 25,000 sources and offer novel tools to extract meaningful insights. Our newest product CLIN delivers the complete universe of immuno-oncology clinical trial data in one, easy-to-navigate platform. That's ten years of trial data, manually reviewed and coded to extract every table, graph, and figure. New data is added as it's released from publications, conferences, and guidelines.
PHC Group develops, manufactures, sells, and services across diabetes management, diagnostics and life sciences, as well as healthcare service businesses. Committed to its corporate mission, “We contribute to the health of society through our diligent efforts to create healthcare solutions that have a positive impact and improve the lives of people,” the company offers value-added products and services to customers in over 125 countries.
Proteome Sciences is a CRO specializing in the analysis of proteins detected by Mass Spectrometry. We offer various Discovery and Targeted Services to characterize proteins and their associated post-translational modifications. By using LC-MS2, SysQuant®, and TMTcalibratorTM methodologies we can detect up to 8,000 of proteins/sample. With our proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up- or down-regulated with disease progression or drug treatment.
Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets. With over 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions.
Agilent brings the power of precision medicine to customers, partners, and patients. Agilent is a partner of choice to pharmaceutical and biotech companies producing innovative diagnostics and therapeutics for the benefit of patients around the world.
evorion biotechnologies offers custom development services and access to a unique, proprietary functional phenomics pipeline for in-depth multi-parametric analysis of thousands of cell-cell interactions at single-cell resolution. For the first time, researchers can connect a single cell’s functional phenotype with multi-omics data, opening up a new realm of novel insights into cancer-immune cell interactions that will revolutionize cell therapies. Let us partner in advancing human medicine by developing the next generation of adoptive cell therapies.
Imaging Endpoints (IE) is an imaging research and core laboratory that provides comprehensive imaging CRO services and technology solutions. IE is one of the largest iCROs globally and is widely recognized for conducting the industry’s most complex trials. IE’s experience spans hundreds of successful trials across all phases of development, including the most high-profile, global registration trials. IE also specializes in novel imaging technologies such as radiomics where the company is the industry leader.
TransCure bioServices (TCS) provides predictive in vivo pharmacology expertise for drug pre-clinical candidate selection in the fields of infectious, cancer (IO, PDX), inflammation, vaccine and immune disease areas. We are the only preclinical CRO providing commercially HIV, immuno-oncology (IO) therapy, PDX, IBD, vaccine and autoimmune mouse models with a fully functional reconstituted HUMAN IMMUNE SYSTEM (hu-mouse models). We co-design study protocols/experiments performing the ordered studies and providing comprehensive data collection, data analysis and reports.
Ultivue provides researchers and scientists with multiplex biomarker assays for tissue phenotyping and digital pathology. Ultivue’s InSituPlex® technology eliminates the need for assay development and enables scientists to unmask and analyze the true biological context of tissue samples. UltiMapper™ kits are fully optimized mIHC panels that provide uninhibited co-localization of multiple markers for deep single-cell phenotyping.
Predicine is a molecular insights company committed to advancing biomarker-driven precision medicine. It has developed a breakthrough cell-free DNA and cell-free RNA based liquid biopsy technology for non-invasive cancer profiling, disease monitoring, assessing MRD, and early cancer detection. Predicine partners with leading biopharma companies and hospitals to support global clinical trials and personalized cancer care.
Personalis, Inc. is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis® ImmunoID NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. Personalis also provides genomic information to the VA Million Veterans Program as part of their goal to sequence over a million veteran genomes. The Personalis Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited. For more information, please visit www.personalis.com and follow Personalis on Twitter (@PersonalisInc).